Answers are grounded in this paper and cite their sources.
Case report demonstrates recurrent sickle cell hepatopathy despite guideline-directed red blood cell exchange in a liver transplant recipient, highlighting the need for stricter hemoglobin S targets.
Sickle cell hepatopathy is an uncommon but severe cause of liver dysfunction after transplantation. We present a case of a 37-year-old man who developed recurrent sickle cell hepatopathy 12 months postliver transplant despite maintaining hemoglobin S (HbS) levels below 30% per American Society of Hematology recommendations. Liver biopsy demonstrated sinusoidal sickling without rejection. Liver tests improved after intensifying red cell exchange to achieve HbS below 20%. This case illustrates that standard posttransplant HbS targets may be insufficient in high-risk patients and highlights the need for individualized HbS goals.
No takes yet. Share an insight, caveat, or question.
Aslam et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: